The Innovation Firm

When

April 25, 2017
8:00 a.m.

Where

Hamilton Brook Smith Reynolds
155 Seaport Blvd., 2nd Floor
Boston, MA 02210

Strategies for Prosecuting Biotech and Life Science Patents in China

On Tuesday, April 25, 2017, Keith Wood will be co-hosing the BPLA International and Foreign Practice Committee seminar titled "Strategies for Prosecuting Biotech and Life Science Patents in China" at Hamilton Brook Smith Reynolds in Boston.

BPLA Event Description:

Come find out about the latest issues and strategies for biotech patents in China. We will get updated on best practices from one of China’s foremost practitioners.

The topics include: procedures, common issues during prosecution, data requirements for different types of inventions, diagnostics, second and subsequent medical use inventions, and rules for filing divisionals.

 

For more information, please visit the BPLA website

  

   Luke ZUO

   Patent Attorney

 

 

 

Luke joined NTD in 2002. Before then, he had been working as a physician in Department of Internal Medicine and then Department of Hematology of PUMC Hospital for nine years. During 1998-2000, he had been working at National Laboratory of Medical Molecular Biology, CAMS & PUMC and participated in a series of study focusing on the pathogenesis of acute leukemia and the molecular mechanism underlying chemotherapeutic agent-induced apoptosis in leukemic cells. After he switched to IP in 2002, Luke has handled a large number of patent applications in biology and medicine related areas, including Molecular Biology, Immunology, Pharmaceuticals and Biotechnology. He has many experiences in patent drafting, prosecution and reexamination, patent infringement, patentability and validity assessment, FTO search and analysis, and lawsuits. Luke represents a full range of clients, from domestic start-ups to MNCs, including some top universities and research institutes in China, and is highly appraised by both foreign and domestic clients for the excellent IP legal services provided by his team. He once studied in a US law firm about the IP system in the States and exchange views on how to better prosecute patent applications in China.

SELECTED CASES

Pfizer Inc. vs a Chinese pharmaceutical company, patent invalidation,representative of the Patentee

ABZYMO Biosciences vs AXIS-SHIELD, patent invalidation, representative of the Requestor

SCA Hygiene Products AB vs Patent Reexamination Board, administrative lawsuits, representative of the Plaintiff

MEMBERSHIP

All-China Patent Attorneys Association (ACPAA), AIPPI

EDUCATION

B.S., Medicine, Shanghai Medical University

MD, Chinese Academy of Medical Sciences & Peking Union Medical College

 

Overview

When

April 25, 2017
8:00 a.m.

Where

Hamilton Brook Smith Reynolds
155 Seaport Blvd., 2nd Floor
Boston, MA 02210

On Tuesday, April 25, 2017, Keith Wood will be co-hosing the BPLA International and Foreign Practice Committee seminar titled "Strategies for Prosecuting Biotech and Life Science Patents in China" at Hamilton Brook Smith Reynolds in Boston.

BPLA Event Description:

Come find out about the latest issues and strategies for biotech patents in China. We will get updated on best practices from one of China’s foremost practitioners.

The topics include: procedures, common issues during prosecution, data requirements for different types of inventions, diagnostics, second and subsequent medical use inventions, and rules for filing divisionals.

 

For more information, please visit the BPLA website

Presenter Bios

  

   Luke ZUO

   Patent Attorney

 

 

 

Luke joined NTD in 2002. Before then, he had been working as a physician in Department of Internal Medicine and then Department of Hematology of PUMC Hospital for nine years. During 1998-2000, he had been working at National Laboratory of Medical Molecular Biology, CAMS & PUMC and participated in a series of study focusing on the pathogenesis of acute leukemia and the molecular mechanism underlying chemotherapeutic agent-induced apoptosis in leukemic cells. After he switched to IP in 2002, Luke has handled a large number of patent applications in biology and medicine related areas, including Molecular Biology, Immunology, Pharmaceuticals and Biotechnology. He has many experiences in patent drafting, prosecution and reexamination, patent infringement, patentability and validity assessment, FTO search and analysis, and lawsuits. Luke represents a full range of clients, from domestic start-ups to MNCs, including some top universities and research institutes in China, and is highly appraised by both foreign and domestic clients for the excellent IP legal services provided by his team. He once studied in a US law firm about the IP system in the States and exchange views on how to better prosecute patent applications in China.

SELECTED CASES

Pfizer Inc. vs a Chinese pharmaceutical company, patent invalidation,representative of the Patentee

ABZYMO Biosciences vs AXIS-SHIELD, patent invalidation, representative of the Requestor

SCA Hygiene Products AB vs Patent Reexamination Board, administrative lawsuits, representative of the Plaintiff

MEMBERSHIP

All-China Patent Attorneys Association (ACPAA), AIPPI

EDUCATION

B.S., Medicine, Shanghai Medical University

MD, Chinese Academy of Medical Sciences & Peking Union Medical College

 

Back to the Top